Long-term treatment of venous thromboembolism with low-molecular-weight heparin

Current Opinion in Pulmonary Medicine ◽

10.1097/00063198-200007000-00013 ◽

2000 ◽

Vol 6 (4) ◽

pp. 326-329 ◽

Author(s):

Manuel Monreal

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Low Molecular Weight Heparin ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Vitamin K antagonists versus low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd002001.pub3 ◽

2017 ◽

Author(s):

Alina Andras ◽

Adriano Sala Tenna ◽

Marlene Stewart

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Low Molecular Weight Heparin ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Meta-analysis of the randomized comparisons between low-molecular weight heparin (LMWH) with oral anticoagulants (OA) for the long-term treatment of symptomatic venous thromboembolism (VTE): no difference in cancer-related mortality

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8145 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8145-8145

Author(s):

G. Ferretti ◽

E. Bria ◽

P. Carlini ◽

A. Felici ◽

D. Giannarelli ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Low Molecular Weight Heparin ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment ◽

Related Mortality

Download Full-text

Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE)

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2003.tb03300.x ◽

2003 ◽

Vol 1 ◽

pp. OC004-OC004 ◽

Author(s):

A. Y. Y. Lee ◽

J. A. Julian ◽

M. N. Levine ◽

R. I. Baker ◽

C. Bowden ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Low Molecular Weight Heparin ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants

Journal of Thrombosis and Haemostasis ◽

10.1046/j.1538-7836.2003.00364.x ◽

2003 ◽

Vol 1 (9) ◽

pp. 1906-1913 ◽

Author(s):

A. Iorio ◽

F. Guercini ◽

M. Pini

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Low Molecular Weight Heparin ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

10.1002/14651858.cd002001 ◽

2001 ◽

Author(s):

Jeroen Frank van der Heijden ◽

Barbara A Hutten ◽

Harry R Büller ◽

Martin H Prins

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Low Molecular Weight Heparin ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Low-Molecular-Weight Heparin Versus Oral Anticoagulant Therapy for the Long-Term Treatment of Symptomatic Venous Thromboembolism: Is There Any Difference in Cancer-Related Mortality?

Journal of Clinical Oncology ◽

10.1200/jco.2005.01.7897 ◽

2005 ◽

Vol 23 (28) ◽

pp. 7248-7250 ◽

Author(s):

Gianluigi Ferretti ◽

Emilio Bria ◽

Diana Giannarelli ◽

Paolo Carlini ◽

Alessandra Felici ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Oral Anticoagulant ◽

Low Molecular Weight Heparin ◽

Oral Anticoagulant Therapy ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment ◽

Related Mortality

Download Full-text

Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

10.1002/14651858.cd002001.pub2 ◽

2012 ◽

Author(s):

Alina Andras ◽

Adriano Sala Tenna ◽

Fay Crawford

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Low Molecular Weight Heparin ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Fixed-dose low-molecular-weight heparin, bemiparin, in the long-term treatment of venous thromboembolism in patients with transient risk factors in standard clinical practice: the FLEBUS study

Journal of Thrombosis and Haemostasis ◽

10.1111/j.1538-7836.2006.02171.x ◽

2006 ◽

Vol 4 (11) ◽

pp. 2504-2508 ◽

Author(s):

R. LECUMBERRI ◽

E. ROSARIO ◽

J. PACHO ◽

E. ROCHA ◽

Keyword(s):

Risk Factors ◽

Molecular Weight ◽

Venous Thromboembolism ◽

Low Molecular Weight Heparin ◽

Term Treatment ◽

Low Molecular Weight ◽

Standard Clinical Practice ◽

Long Term Treatment

Download Full-text

How does low-molecular-weight heparin compare with vitamin K antagonists for long-term treatment of individuals with symptomatic venous thromboembolism?

Cochrane Clinical Answers ◽

10.1002/cca.1823 ◽

2017 ◽

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Vitamin K ◽

Low Molecular Weight Heparin ◽

Vitamin K Antagonists ◽

Term Treatment ◽

Low Molecular Weight ◽

Long Term Treatment

Download Full-text

Intermediate doses of low-molecular-weight heparin for the long-term treatment of pregnancy thromboembolism. A systematic review

Thrombosis and Haemostasis ◽

10.1160/th13-06-0510 ◽

2014 ◽

Vol 111 (03) ◽

pp. 559-561 ◽

Author(s):

Esteban Gándara ◽

Marc Carrier ◽

Marc Rodger

Keyword(s):

Systematic Review ◽

Molecular Weight ◽

Low Molecular Weight Heparin ◽

Term Treatment ◽

Low Molecular Weight ◽

Contact Information ◽

Long Term Treatment ◽

Note: The contact information for Drs. Gandara and Carrier is the same as for Dr. Rodger. Their e-mail addresses are [email protected] and [email protected], respectively.

Download Full-text